Document is current
Any future updates will be listed below
-
Authors
Creswell, Richard
Tan, Jie
Leff, Jonathan W.
Brooks, Brandon
Mahowald, Michael A.
Thieroff-Ekerdt, Ruth
Gerber, Georg K. https://orcid.org/0000-0002-9149-5509
-
Funding
Funding for this research was provided by:
Kaleido Biosciences, Inc. (NA)
National Institute of General Medical Sciences (1R01GM130777)
- License Information
-
More Information
Article History
Received: 27 November 2019
Accepted: 16 June 2020
First Online: 3 July 2020
Ethics approval and consent to participate
: Study protocols and informed consent forms for K001 and K002 were reviewed and approved by Aspire IRB Board. Study protocol and informed consent form for K003 were reviewed and approved by Alpha IRB Board. All human research subjects agreed to participate and signed consent was obtained. Our research conformed to the principles of the Helsinki Declaration.
: Not applicable.
: GKG is a Strategic Advisory Board member and shareholder of Kaleido Biosciences, Inc., and a Scientific Advisory Board member and shareholder of ParetoBio, Inc. GKG has a financial interest in Kaleido Biosciences, Inc., a sponsor of this research. GKG’s financial interests were reviewed and are managed by Brigham and Women’s Hospital and Partners Healthcare in accordance with their conflict of interest policies. JT is an employee, JWL and BB are consultants, and MAM and RTE were previously employees of Kaleido Biosciences, Inc. The remaining authors declare that they have no competing interests.
